ACP-5862

E2104213 UNEXPLORED

ACP-5862 is the primary active metabolite of the Bruton’s tyrosine kinase inhibitor acalabrutinib, contributing significantly to its pharmacologic activity in treating certain B-cell malignancies.

Try in SPARQL Jump to: Surface forms Referenced by

All labels observed (1)

Label	Occurrences
ACP-5862 canonical	1

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

acalabrutinib → hasActiveMetabolite → ACP-5862 ⓘ